Valuation: Novartis AG

Market Cap 290B 251B 235B 215B 404B 27,652B 410B 2,772B 1,082B 13,842B 1,088B 1,064B 46,175B P/E 2026 *
21.7x
P/E 2027 * 18.5x
Enterprise Value 323B 280B 262B 239B 450B 30,812B 457B 3,089B 1,206B 15,424B 1,212B 1,186B 51,452B EV / Sales 2026 *
5.61x
EV / Sales 2027 * 5.2x
Free-Float
91.66%
Yield 2026 *
2.85%
Yield 2027 * 2.98%
1 day-0.17%
1 week-1.15%
Current month-2.26%
1 month-0.67%
3 months+5.94%
6 months-1.12%
Current year+12.90%
1 week 123.02
Extreme 123.02
127.66
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap.
17/02/26 Sell 30,743 0.0015%
10/02/26 Sell 7,500 0.0004%
09/02/26 Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%-1.15%+26.89%+36.10% 291B
-0.76%+1.81%+83.72%+125.55% 1,088B
+0.16%+1.72%+49.87%+50.72% 629B
+0.44%+2.35%+23.89%+63.92% 440B
-0.88%-0.66%+45.09%+36.79% 359B
+0.05%-1.20%+2.31%+5.34% 245B
+0.29%+3.00%+44.12%+59.78% 225B
-0.42%+1.58%-8.48%-51.84% 204B
+1.18%+4.77%+14.12%+71.70% 168B
+1.54%+1.98%+6.19%-25.93% 150B
Average +0.16%+1.62%+28.77%+37.21% 379.92B
Weighted average by Cap. -0.11%+2.04%+44.49%+61.23%

Financials

2026 *2027 *
Net sales 57.58B 49.91B 46.79B 42.66B 80.28B 5,496B 81.56B 551B 215B 2,751B 216B 212B 9,177B 61.12B 52.98B 49.67B 45.29B 85.21B 5,834B 86.57B 585B 228B 2,920B 229B 225B 9,741B
Net income 13.78B 11.94B 11.2B 10.21B 19.21B 1,315B 19.52B 132B 51.47B 658B 51.74B 50.62B 2,196B 15.36B 13.31B 12.48B 11.38B 21.41B 1,466B 21.75B 147B 57.36B 734B 57.66B 56.41B 2,448B
Net Debt 33.11B 28.7B 26.91B 24.53B 46.16B 3,160B 46.9B 317B 124B 1,582B 124B 122B 5,277B 27.82B 24.11B 22.6B 20.61B 38.78B 2,655B 39.4B 266B 104B 1,329B 104B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
13/08/26 CHF 123.74 -0.37% 1,625,128
12/08/26 CHF 124.20 -1.32% 2,069,949
11/08/26 CHF 125.86 -0.74% 1,913,995
10/08/26 CHF 126.80 +0.65% 1,791,666
07/08/26 CHF 125.98 +0.64% 1,873,459
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
153.00USD
Average target price
154.18USD
Spread / Average Target
+0.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock